Sabra Health Care REIT (SBRA) Return on Sales (2015 - 2026)

Sabra Health Care REIT's Return on Sales history runs 12 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.01%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Sales rose to 0.0% in Q1 2026 per SBRA's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q1 2022 and bottomed at 0.0% in Q3 2022.
• The 5-year median for Return on Sales is 0.0% (2024), against an average of 0.0%.
• Across the five-year window, Return on Sales climbed 1 bps in 2022 and declined 1 bps in 2023, its largest moves.
• Year by year, Return on Sales stood at 0.0% in 2022, then sank by 41 bps to 0.0% in 2023, then surged by 1506 bps to 0.01% in 2024, then sank by 120 bps to 0.0% in 2025, then surged by 242 bps to 0.0% in 2026.
• Per Business Quant, the three latest SBRA Return on Sales figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).